echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Takeda's 100 microgram dose of Natpara will be withdrawn for 1 year

    Takeda's 100 microgram dose of Natpara will be withdrawn for 1 year

    • Last Update: 2021-04-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    CompilationFan Dongdong

    Takeda announced in an open letter to the Hypoparathyroidism Association and the broader hypoparathyroidism patients and the medical community that 100 micrograms of Natpara may be interrupted as early as this week due to shortage of supply.


    The company’s U.


    Takeda Natpara injection is a recombinant human protein with a full-length 84 amino acid sequence of endogenous parathyroid hormone (PTH).


    In 2019, Takeda announced the recall of all injection dosage specifications of Natpara injection in the US market.


    In addition to the recall, manufacturing delays have also delayed the company's previously anticipated timetable.


    Reference source:

    1.


    2.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.